100% Arcus - and it's fascinating learning about it! So much potential here and it will be recognised some enough. Talking about IMU, the exact same thing happened over there at a similar stage. Once the circles get a hold of what the recent data actually means and we get closer to more newsflow, pipeline additions, regulatory milestone announcements we will see a re-rate and it will come quickly IMHO. It was interesting in yesterdays NWR Healthcare event presentation Jen mentioned growing the pipeline with NK Cells and Macrophages again twice. There is a company out of the US (private company - Seed round funded) who have seen some good data from their Phase I Car-Macrophage trials. 101 has some serious promise, and I haven't had much time at all lately to do research but I wonder if we could arm a Car-Macrophage with CLTX would it provide another shot on goal?
CHM Price at posting:
27.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)